(Q57479549)

English

A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression

No description defined

Statements

A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression (English)
0 references
0 references
Sara A. Corya
0 references
Paul E. Keck
0 references
Daniel Y. Lin
0 references
Michael G. Case
0 references
Doug J. Williamson
0 references
Mauricio F. Tohen
0 references
15 May 2006
0 references
67
0 references
05
0 references
798-806
0 references

Identifiers

0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit